Badoux, X. C., Keating, M. J., Wang, X., O'Brien, S. M., Ferrajoli, A., Faderl, S., . . . Wierda, W. G. (2011). Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. American Society of Hematology.
Citação norma ChicagoBadoux, Xavier C., et al. Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients With CLL. American Society of Hematology, 2011.
Citação norma MLABadoux, Xavier C., et al. Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients With CLL. American Society of Hematology, 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.